The proteolytic effect of bromelain on bullous pemphigoid antigen-2 - 18/09/16
Doi : 10.1016/j.jaad.2016.05.025
Matthew D. Belcher, MD ⁎ 
, Ismail Kaddour-Djebbar, MD, Wendy B. Bollag, PhD, Loretta S. Davis, MD
, Ismail Kaddour-Djebbar, MD, Wendy B. Bollag, PhD, Loretta S. Davis, MD Division of Dermatology, Medical College of Georgia at Augusta University, and Charlie Norwood VA, Medical Center, Augusta
∗Correspondence to: Matthew D. Belcher, MD, 1004 Chafee Avenue, FH 1001004 Chafee Avenue, FH 100
| The first two authors contributed equally to the work. |
|
| Funding sources: Funding for this study was provided by the Division of Dermatology at Augusta University. |
|
| Conflicts of interest: Wendy B. Bollag, PhD, is supported by a VA Research Career Scientist Award. The other authors declare no relevant financial interest. |
|
| The contents of this article do not represent the views of the Department of Veterans Affairs or the United States Government. |
© 2016
American Academy of Dermatology, Inc. Tous droits réservés.
Vol 75 - N° 4
P. 838-840 - octobre 2016 Retour au numéro
Article précédent
- Blue-gray blotch: A helpful dermoscopic finding in optimal biopsy site selection for true vasculitis
- Ji Yoon Choo, Jung Min Bae, Ji Hyun Lee, Jun Young Lee, Young Min Park
- The cutaneous expression of vitamin K-dependent and other osteogenic proteins in calciphylaxis stratified by clinical features and warfarin use: A case control study
- Frances Tian, Andrew T. Patterson, Jonathan J. Davick, Steven W. Ing, Benjamin H. Kaffenberger, Alejandro A. Gru
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?